Search

Your search keyword '"Merion RM"' showing total 277 results

Search Constraints

Start Over You searched for: Author "Merion RM" Remove constraint Author: "Merion RM"
277 results on '"Merion RM"'

Search Results

3. Intravenous mycophenolate mofetil: safety, tolerability, and pharmacokinetics

5. Phenotyping Men With Lower Urinary Tract Symptoms: Results From the Symptoms of Lower Urinary Tract Dysfunction Research Network.

6. How Do Financial Obstacles Affect Decision-Making Among Potential Living Organ Donors?

7. Living Donor Decision-Making and the Complex Interplay of Finances and Other Motivators, Barriers, and Facilitators.

8. Use of Federal Reimbursement for Living Donor Costs by Racial and Ethnic Minorities: Implications for Disparities in Access to Living Donor Transplantation.

9. Serum bile acids as a prognostic biomarker in biliary atresia following Kasai portoenterostomy.

10. Serum biomarkers correlated with liver stiffness assessed in a multicenter study of pediatric cholestatic liver disease.

11. Comparing clinical bladder diaries and recalled patient reports for measuring lower urinary tract symptoms in the symptoms of Lower Urinary Tract Dysfunction Research Network (LURN).

12. Subtyping of common complex diseases and disorders by integrating heterogeneous data. Identifying clusters among women with lower urinary tract symptoms in the LURN study.

13. Nonfasted Liver Stiffness Correlates with Liver Disease Parameters and Portal Hypertension in Pediatric Cholestatic Liver Disease.

14. Satisfaction with life and depressive symptoms in living organ donors and non-donors: New insights from the National Living Donor Assistance Center.

15. Best practices to optimize utilization of the National Living Donor Assistance Center for the financial assistance of living organ donors.

16. Symptom Based Clustering of Men in the LURN Observational Cohort Study.

17. Reply by Authors.

18. Are three-day voiding diaries feasible and reliable? Results from the Symptoms of Lower Urinary Tract Dysfunction Research Network (LURN) cohort.

19. Clustering of the structures by using "snakes-&-dragons" approach, or correlation matrix as a signal.

20. Life and expectations post-kidney transplant: a qualitative analysis of patient responses.

21. Comparison of patient and provider goals, expectations, and experiences following kidney transplantation.

22. Symptom Based Clustering of Women in the LURN Observational Cohort Study.

23. Bowel function, sexual function, and symptoms of pelvic organ prolapse in women with and without urinary incontinence.

24. Mental Health, Sleep and Physical Function in Treatment Seeking Women with Urinary Incontinence.

25. Kidney transplant graft outcomes in 379 257 recipients on 3 continents.

26. Return on investment for financial assistance for living kidney donors in the United States.

27. Estimating the effect of a rare time-dependent treatment on the recurrent event rate.

28. Reasons for Seeking Clinical Care for Lower Urinary Tract Symptoms: A Mixed Methods Study.

29. Prevalence and Predictors of Patient-Reported Long-term Mental and Physical Health After Donation in the Adult-to-Adult Living-Donor Liver Transplantation Cohort Study.

30. Biliary reconstructive techniques and associated anatomic variants in adult living donor liver transplantations: The adult-to-adult living donor liver transplantation cohort study experience.

31. Evidence of the Impact of Diet, Fluid Intake, Caffeine, Alcohol and Tobacco on Lower Urinary Tract Symptoms: A Systematic Review.

32. Hepatic Hemodynamics and Portal Flow Modulation: The A2ALL Experience.

33. National assessment of early hospitalization after liver transplantation: Risk factors and association with patient survival.

34. The National Living Donor Assistance Center perspective on barriers to the use of federal travel grants for living donors.

35. HLA Amino Acid Polymorphisms and Kidney Allograft Survival.

36. Acute Rejection Increases Risk of Graft Failure and Death in Recent Liver Transplant Recipients.

37. National Assessment of Hospitalization Rates for Incident End-Stage Renal Disease After Liver Transplantation.

38. Recurrent primary sclerosing cholangitis in the Adult-to-Adult Living Donor Liver Transplantation Cohort Study: Comparison of risk factors between living and deceased donor recipients.

39. Patterns of Early Allograft Dysfunction in Adult Live Donor Liver Transplantation: The A2ALL Experience.

40. Symptoms of Lower Urinary Tract Dysfunction Research Network.

41. Psychosocial Outcomes 3 to 10 Years After Donation in the Adult to Adult Living Donor Liver Transplantation Cohort Study.

42. Complications and Their Resolution in Recipients of Deceased and Living Donor Liver Transplants: Findings From the A2ALL Cohort Study.

43. Misclassification Errors in Unsupervised Classification Methods. Comparison Based on the Simulation of Targeted Proteomics Data.

44. Defining long-term outcomes with living donor liver transplantation in North America.

45. Serum sodium and survival benefit of liver transplantation.

46. Changes in liver and spleen volumes after living liver donation: a report from the Adult-to-Adult Living Donor Liver Transplantation Cohort Study (A2ALL).

47. Long-term quality of life after liver donation in the adult to adult living donor liver transplantation cohort study (A2ALL).

48. Satisfaction With Life Among Living Kidney Donors: A RELIVE Study of Long-Term Donor Outcomes.

49. Outcomes of liver transplantation for porto-pulmonary hypertension in model for end-stage liver disease era.

50. Morbidity and mortality of live lung donation: results from the RELIVE study.

Catalog

Books, media, physical & digital resources